United States
# |
Name |
EBIT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
65.20%
|
Sept. 30, 2024 | USD 39.22 | 1.63% |
|
United States |
|
2 |
25.34%
|
Sept. 29, 2024 | USD 144.75 | 0.19% |
|
United States |
|
3 |
18.69%
|
Sept. 30, 2024 | USD 627.71 | 1.49% |
|
United States |
|
4 |
18.10%
|
Oct. 31, 2024 | USD 72.63 | 1.31% |
|
United States |
|
5 |
17.92%
|
Sept. 30, 2024 | USD 17.68 | 0.68% |
|
United States |
|
6 |
17.32%
|
Nov. 2, 2024 | USD 36.79 | 0.03% |
|
United States |
|
7 |
13.89%
|
Nov. 2, 2024 | USD 404.06 | 0.03% |
|
United States |
|
8 |
7.08%
|
Sept. 30, 2024 | USD 5.67 | 2.35% |
|
United States |
|
9 |
6.96%
|
Sept. 28, 2024 | USD 35.65 | -0.17% |
|
United States |
|
10 |
6.79%
|
Sept. 30, 2024 | USD 6.18 | -4.33% |
|
United States |
|
11 |
6.44%
|
Sept. 30, 2024 | USD 4.15 | -1.66% |
|
United States |
|
12 |
4.75%
|
Nov. 2, 2024 | USD 11.50 | 1.23% |
|
United States |
|
13 |
3.89%
|
Sept. 30, 2024 | USD 38.98 | 0.72% |
|
United States |
|
14 |
2.63%
|
Nov. 9, 2024 | USD 59.92 | 0.72% |
|
United States |
|
15 |
2.61%
|
Sept. 30, 2024 | USD 51.57 | 0.10% |
|
United States |
|
16 |
2.59%
|
Sept. 28, 2024 | USD 63.79 | -0.65% |
|
United States |
|
17 |
2.33%
|
Sept. 28, 2024 | USD 66.75 | 0.48% |
|
United States |
|
18 |
2.00%
|
Nov. 30, 2024 | USD 20.73 | 0.34% |
|
United States |
|
19 |
1.95%
|
Sept. 30, 2024 | USD 17.80 | 3.01% |
|
United States |
|
20 |
1.26%
|
Sept. 30, 2024 | USD 593.73 | 1.48% |
|
United States |
|
21 |
1.17%
|
Sept. 26, 2024 | USD 95.99 | -0.72% |
|
United States |
|
22 |
0.76%
|
Sept. 30, 2024 | USD 240.05 | 1.68% |
|
United States |
|
23 |
0.66%
|
Sept. 30, 2024 | USD 14.98 | -0.13% |
|
United States |
|
24 |
0.65%
|
Sept. 30, 2024 | USD 54.16 | 0.43% |
|
United States |
|
25 |
-0.62%
|
Sept. 30, 2024 | USD 4.88 | 0.62% |
|
United States |
|
26 |
-1.84%
|
Sept. 30, 2024 | USD 11.72 | -0.68% |
|
United States |
|
27 |
-3.36%
|
Sept. 30, 2024 | USD 8.97 | -1.75% |
|
United States |
|
28 |
-3.67%
|
Sept. 30, 2024 | USD 12.40 | -1.20% |
|
United States |
|
29 |
-7.57%
|
Sept. 30, 2024 | USD 1.64 | -2.96% |
|
United States |
|
30 |
-7.76%
|
Dec. 31, 2023 | USD 3.79 | 1.24% |
|
United States |
|
31 |
-9.29%
|
Nov. 30, 2024 | USD 12.24 | 2.86% |
|
United States |
|
32 |
-10.08%
|
Sept. 30, 2024 | USD 42.32 | NA |
|
United States |
|
33 |
-29.81%
|
Sept. 30, 2024 | USD 1.05 | -7.08% |
|
United States |
The Drugstores & Retail Pharmacies company in United States with the highest EBIT Margin is National Retail Properties, Inc. (NYSE: NNN) at 65.20%.
The Drugstores & Retail Pharmacies company in United States with the lowest EBIT Margin is Biofrontera Inc. (NasdaqCM: BFRI) at -29.81%.
The top 10 Drugstores & Retail Pharmacies companies in United States by EBIT Margin are National Retail Properties, Inc., Johnson & Johnson, Lennox International Inc., Brady Corporation, Innoviva, Inc., Bath & Body Works, Inc., Ulta Beauty, Inc., biote Corp., Sturm, Ruger & Company, Inc. and Herbalife Nutrition Ltd..
The bottom 10 Drugstores & Retail Pharmacies companies in United States by EBIT Margin are Biofrontera Inc., Omnicell, Inc., Walgreens Boots Alliance, Inc., Pilulka Lékárny a.s., Aytu BioPharma, Inc., ShotSpotter, Inc., Icahn Enterprises L.P., Viatris Inc., PetMed Express, Inc. and ANI Pharmaceuticals, Inc..